Assessment of bleeding events in clinical trials--proposal of a new classification.

@article{Serebruany2007AssessmentOB,
  title={Assessment of bleeding events in clinical trials--proposal of a new classification.},
  author={Victor L. Serebruany and Dan Atar},
  journal={The American journal of cardiology},
  year={2007},
  volume={99 2},
  pages={288-90}
}
Present classifications of bleeding events used in antithrombotic and/or antiplatelet clinical trials are based on the criteria developed by the Thrombolysis In Myocardial Infarction (TIMI) and Global Use of Strategies to Open Coronary Arteries (GUSTO) groups. Introduced more than a decade ago, the 2 classifications used the criteria to better categorize… CONTINUE READING